Related Experiment Video
Updated: Mar 1, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Drug-related problems in hospitalized oncology patients, with special focus on radiotherapy units: Implications for
Katarzyna Regulska1,2, Marcin Michalak3, Beata Janiszewska4
1Hospital Pharmacy, Greater Poland Cancer Centre, Garbary 15 Street, 61-866 Poznan, Poland.
Abstract:
IntroductionDrug-related problems (DRPs) represent a major challenge in contemporary oncology. In healthcare systems with limited clinical pharmacy resources, identification of high-risk patient groups and treatment settings is - from a clinical pharmacology perspective - essential to prioritize pharmacotherapeutic surveillance.MethodsThis single-centre, retrospective, high-risk cohort study analysed pharmacotherapy in 31 adult cancer patients hospitalized in a comprehensive oncology centre in Poland. Patients were selected for medication review based on clinicians' suspicion of pharmacotherapy-related problems during hospitalization. DRPs were identified and classified according to the Pharmaceutical Care Network Europe classification version 9.1, focusing on pharmacotherapy-related complications rather than individual prescribing errors. Sociodemographic, clinical and pharmacotherapeutic variables were analysed. Statistical analyses were exploratory and hypothesis-generating.ResultsAt least one DRP was identified in 29 out of 31 patients (94%). The most frequent DRPs were adverse drug reactions and drug therapy without a clearly documented current indication, predominantly involving proton pump inhibitors (PPIs). Antimicrobials, drugs for acid-related disorders and psycholeptics accounted for the highest number of DRPs. A numerically higher risk of DRPs was observed in patients with impaired renal function, excessive polypharmacy (≥ 10 drugs) and those receiving non-surgical treatment, particularly radiotherapy.ConclusionHospitalized oncology patients with suspected pharmacotherapy-related complications are at high risk of DRPs. From an oncology pharmacy perspective, targeted medication review appears to be a rational approach to identify and mitigate pharmacotherapy-related risks in this setting. Radiotherapy units, patients with impaired renal function, antimicrobials and PPI use or extensive polypharmacy represent priority areas for enhanced clinical pharmacy involvement.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Pharmaceutical Poisoning: Potential Scenarios
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drug Therapy
Antianxiety Medications
Drug Dosing: Geriatric Patients

